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ABSTRACT 
 
 
DJ-1 is a cytosolic sensor for oxidative damage which acts on the 
Mitochondria. It works to curb the negative effects of high membrane potential in 
mitochondria, but the mechanism of action is still uncertain. This study measured 
DJ-1’s potential in enchancing mitochondrial quality control in the context of 
pancreatic B-cells treated with a palmitate and glucose media to promote 
glucolipotoxicity (GLT). DJ-1 was proven capable of reversing GLT induced 
changed in mitochondrial morphology in the arenas of Feret’s diameter, aspect 
ratio, and form factor. We also showed that the mitochondrial membrane 
potential did not vary with the presence or absence of DJ-1. In addition, DJ-1 was 
shown capable of limiting the upward boundary of GLT induced increase in 
mitochondrial membrane potential. Furthermore, an experiment using INS1 cells 
with GFP-LC3 showed that DJ-1 can decrease the average number of 
autophagosomes in the cell. 
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INTRODUCTION 
Mitochondria 
Mitochondria are organelles found in eukaryotic cells and possess two 
separate membranes. They contain their own DNA and also grow and reproduce 
independently from the rest of the cell. These qualities have lent support to the 
endosymbiotic theory that states that the mitochondria was once an oxygen 
producing, non-photosynthetic prokaryote which was engulfed by a eukaryotic 
cell, resulting in a symbiotic relationship (Embley 2006). Mitochondria perform 
many functions for the cell including fatty acid metabolism along with amino acid 
and iron-sulfur cluster production. Most notably, the mitochondria is responsible 
for producing the ‘energy currency of the cell’, ATP, through the process of 
oxidative phosphorylation. An unavoidable byproduct of this process is the 
generation of reactive oxygen species (ROS), which can disrupt the cell’s activity 
and health greatly. Thus the mitochondria is both evolutionarily essential for 
eukaryotic cellular function and also a source of potentially damage causing 
molecules (Fischer et al 2012).  
 
Quality Control 
Mitochondrial quality control (MQC) is the set of pathways the cell 
employs in order to contain and reduce damage due to ROS at the molecular, 
organellar, and cellular level.  While harmful in large amounts, low concentrations 
of ROS are necessary for several cell signaling pathways. Higher concentrations 
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can cause damage to lipids, proteins and also nucleic acids through the removal 
of electrons (Fischer et al 2012). In addition, there is a relationship between ROS 
concentrations and membrane potential (∆ᴪm) in that depolarization of a 
mitochondria causes decreased ROS production (Joselin 2012).  
One method the cell uses to enact MQC is by converting ROS into less 
harmful compounds. Superoxide is the major ROS created at the respiratory 
chain and can be converted into H2O2 with the help of the enzyme superoxide 
dismutase. The H2O2 can then then be acted upon in the mitochondria by the 
antioxidant enzymes peroxiredoxin or glutathione reductase in order to form 
water. Such scavenging methods are unable to fully quell the ongoing molecular 
damage brought on by ROS, but are able to slow down the process.  
Another strategy of MQC is to repair damaged cellular components. In 
order to repair mitochondrial DNA (mtDNA), mitochondria utilize base excision 
repair, mismatch repair and direct reversal. Protecting mtDNA is essential to 
mitochondrial health since it codes for several mitochondrial tRNA, RNA, and 
proteins. In addition, chaperone proteins are able to rescue the three-
dimensional structure of misfolded mitochondrial proteins. These heat shock 
proteins (Hsp) include Hsp22, Hsp60, and Hsp70. While some damage can be 
repaired, most proteins undergo irreversible damage from ROS and must be both 
removed and replaced (Fischer et al 2012).  
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Quality Control Pathway: Mitochondrial Dynamics 
Another avenue of MQC involves the process of mitochondrial dynamics, 
which includes the fusion, fission, selective depolarization, and possible 
autophagy of mitochodnria (mitophagy). The act of fusion creates networks with 
continuous matrix lumen and membranes which allow for the rapid transfer of 
soluble proteins, and other solutes or metabolites. The exchange of 
mitochondrial DNA and membrane embedded proteins occurs much slower. This 
mutual exchange process lowers the heterogeneity of the healthy mitochondrial 
population. Fission is highly important because it produces unequal daughter 
mitochondria: each of the two groups has a ∆ᴪm that usually differ by 5 mV or 
more. The group with the higher ∆ᴪm is likely to undergo future fusion while the 
group with lower ∆ᴪm is less likely to fuse. The mitochondria with decreased ∆ᴪm 
hold a much greater amount of oxidized and damaged material and are much 
more likely to undergo autophagy. Thus, through numerous cycles of fusion and 
fission the quality and health of the mitochondrial population is further maintained 
(Twig et al 2008, Ferree et al 2012).  
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Figure 1: Mitochondrial life cycle.  Figure taken from Wikstrom et al. 2009 
 
Autophagy 
Autophagy is the cellular method of recycling the components of damaged 
or unneeded organelles. The process involves the progression of the dual 
membrane phagophore to the autophagosome (AP). Upon acquisition of the 
damaged or unneeded cellular material, acidification occurs. Next, the AP fuses 
with the lysosome to produce the autolysosome, which degrades the 
aforementioned cellular components (Las et al 2011). In order to quantify the 
process of autophagy, the cytosolic protein marker for autophagy, LC3 
(microtubule-associated protein 1 light chain 3), is used. Upon the onset of 
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autophagy, LC3 is lipidated and binds to the AP membrane, where it stays until it 
is either released or degraded.  
 
DJ-1  
DJ-1 is a cytosolic chaperone protein that acts as a sensor of 
mitochondrial oxidative stress and subsequently translocates to the mitochondria 
once it is oxidized (Dekker et al 2003).  In the last few years, the function of DJ-1 
has been more closely tied to the genes Pink1, and Parkin in the capacity of 
maintaining mitochondrial dynamics and MQC (Irrcher et al. 2010, Thomas et al. 
2011). DJ-1, PINK1, and Parkin are three genes which cause parkinsonism when 
present in their recessive form. DJ-1 acts on mitochondria that have normal to 
higher membrane potential and higher ROS production, while PINK1 acts on 
mitochondria that have lower membrane potential and lower ROS levels. The 
downstream effector Parkin acts on the parallel DJ-1 and PINK1 pathways to 
maintain proper selective autophagic degradation of the mitochondria on both 
extremes (Ferree 2012). It is important to note that while Parkin can rescue the 
effect of both DJ-1 or Pink1, the opposite is not true since neither DJ-1 nor 
PINK1 can abrogate the effect of Parkin (Irrcher et al 2010; Dodson and Guo 
2007). The loss of DJ-1 leads to disruptions in mitochondrial morphology and 
function such as loss of mitochondrial polarization, mitochondrial fragmentation, 
and lack of decreased autophagic clearance (Ferree 2012; Irrcher et al 2010; 
Thomas et al 2011). In addition, DJ-1 knockout in Drosophila has been 
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implicated in decreased AKT signaling (Yang et al 2005)(read in Dagda and Chu 
2009). Furthermore, the antioxidant Pyrroloquinoline quinone (PQQ), was shown 
to increase the levels of the active reduced form of DJ-1 (Nunome et al 2008). 
Also, the amino acid cysteine at the site 106 is what allows DJ-1 to function in 
this capacity (Canet-Aviles et al 2004). Unfortunately, the precise pathway in 
which DJ-1 modulates ROS production is uncertain. Two potential sources of 
clarity in this regard involve modulation of uncoupling protein expression and also 
regulation of complex I activity (Hayashi et al 2009).  
 
Diabetes  
Diabetes is a significant public health concern affecting more than 347 
million people worldwide, with the highest prevalence in India, China, and the 
United States(Danaei et al, WHO 2009). In 2004, and estimated 3.4 million 
people died worldwide from complications of diabetes (WHO fact sheet).  
According to the U.S. Centers for Disease Control and Prevention, diabetes 
affects 25.8 million people or 8.3% of the U.S. population, with 18.8 million 
diagnosed and 7 million undiagnosed (CDC). Furthermore, more than 79 million 
U.S. citizens are estimated to be pre-diabetic. Over time, diabetes can damage 
the heart, blood vessels, eyes, kidneys, and nerves (WHO 2009). Diabetes is the 
leading cause of kidney failure, non-traumatic lower limb amputations, and new 
cases of blindness among adults in the United States. In addition to the 
immediate health risks, the financial toll is a heavy burden. In 2012, the total cost 
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of diagnosed diabetes in the U.S. was estimated to be $245 billion with $176 
billion in direct medical costs and $69 billion for reduced productivity.  
 
 
Figure 2: International prevalence of diabetes. Data includes adults age 
35-64 in 2000 as well as a 2030 estimate. The darker areas represent areas of 
higher prevalence in terms of percentage of total individuals in the age group in 
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that country. Figure downloaded from “ WHO at 
http://www.who.int/diabetes/actionnow/en/DANbooklet.pdf 
 
Modeling Diabetes  
Type 2 diabetes involves a decrease in both pancreatic B-cell mass and 
function as well as an increase in peripheral insulin resistance. These factors 
result in a profound weakening of glucose homeostasis. These impairments in 
Type 2 Diabetes are often the result of a toxic overabundance of nutrients: free 
fatty acids (FFAs)(“lipotoxicity), glucose (“glucotoxicity”), or both glucose and 
FFAs (“glucolipotoxicity”). The net result of these toxicities is an increased 
predilection for apoptotic cell death and reduced insulin secretion (Las et al 2011; 
El-Assaad et al 2003; Poitout et al 2008). Las et al showed that the fatty acid 
Palmitate could both increase the size and number of Aps due to increased 
content of AP substrates. They did this using INS1 treated with 0.4 mM palmitate 
for 14hours with GFP-LC3 as the method of tracking APs. In addition, palmitate 
was found to increase the rate of formation of APs without autophagy reaching a 
steady state in the first 24 hours (rate of formation = rate of degradation).  
 
The Present Experiment 
The point of this experiment is to gain a further I hypothesize that DJ-1 will 
be able to decrease the mean membrane potential of the mitochondrial 
population in cells with nutrient overload. Morphology was quantified in the INS1 
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cells lacking GFP-LC3 using three variables: Feret’s diameter, aspect ratio, and 
form factor. Feret’s diameter quantifies the longest line that can be drawn 
through a shape. Aspect ratio compares the length of the major axis to the minor 
axis such that a perfect circle has an aspect ratio of one. Form factor is equal to 
the theoretical area over the actual area or (Perimeter^2)/(4◦3.14◦ Area). I also 
hypothesize that DJ-1 will substantially reverse the fragmented morphological 
phenotype associated with nutrient overload and lead to more elongated 
structures. The other INS1 cell line used utilized GFP-LC3 in order to quantify the 
number of APs. I hypothesize that DJ-1 will attenuate the effects of nutrient 
overload on autophagy by increasing the size and number of the APs present in 
the cell.  
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 Methods 
 
DJ-1 DNA 
 The DNA used in these experiments were among nine samples of DJ-1 
DNA constructs generously shared by the laboratory of Mark Cookson Ph.D at 
the National Institute of Health. Six of the constructs were pLenti 6 vectors 
(Invitrogen) for lentiviral based expression in target protein. The pLenti 6 vectors 
contained a C-terminus V5 epitope. The other three samples of DNA were 
pcDNA 3.2 vectors which are delivered to the cell via non-lentiviral transfection. 
These pcDNA vectors are advantageous in that they contain an ampicillin 
resistance gene and a pUC origin for selection and maintenance in E.coli. Out of 
these three vectors, the DJ-1 wild type gene and the DJ-1 C106A mutant were 
used. As these plasmids were spotted onto filter paper, each of the circled 
regions were cut out and placed into an Eppendorf tube. Then 50μl of QIAGEN 
elution buffer was added and the mixture was microcentrifuged for 1 minute at 
(rpm) in order to elute the DNA samples.  
 
Transforming E.coli  
Next, the DJ-1 WT and the DJ-1 C106A mutant were used to transform 
E.coli which was specifically grown for the growth and purification of plasmid 
DNA that will be digested by a restriction enzyme. This transformation method 
required adding 10ul of the DNA elution (or ligation?) product and 50ul of E.coli 
(gently thawed on ice since stored at -80°C) to an Eppendorf tube. After 30 
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minutes incubation on ice and 30seconds incubation in a 42°C water bath 
followed by another 2 minutes of incubation on ice the heat shock was complete. 
200ul of S.O.C. medium was added and the solution was incubated in a shaking 
incubator (37°C, 225rpm) for 1 hour. Subsequently, 100ul of the E.coli/DNA 
solution was applied (dropwise with a sterile tip) to an agar plate which had been 
incubated at 37°C for the same hour and which contained ampicillin. The plate 
was evenly coated using a sterilized triangle scraper, the lid was sterilized in 
flame, and the plate was incubated at 37°C overnight.  
  
Mini and Maxi Preps 
In order to grow up a specific colony of recombinant bacteria, 5g of LB 
broth was added to 250ml of distilled water in a 1L Erlenmeyer flask. The flask 
was covered with both aluminum foil and autoclave tape and then autoclaved on 
a gravity 30 setting. After the flask cooled to room temperature, 250ul (1000x) of 
ampicillin was added and the mixture was inoculated by one colony from the 
aforementioned agar plate containing the E.coli/DNA. This LB media mixture was 
placed in a 37°C shaking incubator (300rpm) overnight. Next the bacterial pellet 
was harvested and the plasmid DNA was purified using a MiniPrep procedure 
(QIAGEN). The first steps of this procedure involved the re-suspension of the 
bacterial pellet in a buffer containing RNase A, the addition of an alkaline cell 
lysis solution followed by gentle mixing, and incubation at room temperature for 5 
minutes. Next, a neutralization buffer was added to stop the cell lysis reaction, 
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the mixture was thoroughly mixed, and it was incubated on ice for 5 minutes. 
This mixture (1-2ml) was then microcentrifuged (12,000rpm) and the resulting 
clear supernatant was applied to an equilibrated QIAGEN column and allowed to 
enter the resin by gravity flow. Dyes, RNA, low molecular-weight impurities, and 
proteins were removed from the column using a medium-salt wash buffer and the 
DNA plasmid remaining on the resin of the column was eluted by a high-salt 
buffer. The DNA was desalted following addition of isopropanol and after 
microcentrifugation at 15,000x g rpm for 30 minutes and subsequent decanting, a 
DNA pellet was isolated. 70% ethanol was then added, the mixture was 
microcentrifuged at 15,000x g rpm for 10 minutes, and decanted and allowed to 
air dry for 5 minutes. The final DNA pellet was then dissolved in de-ionized water.   
In order to verify that that bacterial colony used housed the correct DNA 
(as opposed to a source of contamination), the MiniPrep purified DNA was 
analyzed using gel electrophoresis. After verification of the bacterial colony, 
another round of LB media was cultured and inoculated from the same bacterial 
colony. The resulting bacterial pellet’s DNA plasmid was purified using a 
MaxiPrep kit (QIAGEN), which used a larger quantity of the same reagents used 
in each step of the MiniPrep kit and thus required the use of a full sized 
centrifuge instead of a microcentrifuge. The purpose of the MaxiPrep was to 
increase the amount of transfection grade DJ-1 and DJ-1 C106A.  
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Transfection 
 The transfection reagent used in these experiments was Lipofectamine 
2000 (Invitrogen). This reagent mediates the process of lipofection, where a 
cationic liposome complexes with anionic DNA in order for the DNA to overcome 
the electrostatic repulsion of the cell membrane and enter the cell. In addition, 
Lipofectamine 2000 is thought to help the DNA enter the nuclear envelope, 
allowing for highly efficient transfection. Furthermore, the transfection efficiency 
is influenced by factors such as cell density, DNA and liposome concentrations, 
DNA-liposome complexing time, and the inclusion or exclusion of media 
ingredients such as serum or antibiotics (Dalby 2004). Thus Opti-MEM reduced 
serum media (Invitrogen) was used to dilute Lipofectamine 2000. Approximately 
700,000 cells, producing a 90-95% confluency, were plated into each of three 
wells in a 24 well plate for each of the two cell lines used in the experiment.  DJ-1 
plasmid DNA was cotransfected with mitochondrially targeted GFP for the INS1 
cells or mitochondrially targeted DS Red for the LC3-GFP cells in order to 
determine transfection efficiency.  
 
Cell lines 
Cell lines used in these experiments were the pancreatic B-cell lines INS1 
and also a line of INS1 cells with GFP-LC3. Both cell lines were bathed in an 
INS1 media consisting of RPM11640 medium (Invitrogen) supplemented by 10% 
FBS, 10mM HEPES buffer, 1mM pyruvate, 50uM 2-B-mercaptoethanol (added 
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working aliquot, not stock, in order to maintain effectiveness), 50 units/ml 
penicillin, and 50 ug/ml streptomycin. Cells were housed in 500ml cell culture 
flasks (Corning). When splitting flasks of cells approximately twice each week, 
trypsin was used to end the adherence of the cells to the flask. After about 5 
minutes, cells were pipetted out, spun down, new media was added, and the 
resulting mixture was added to a fresh cell culture flask. Cells were stored in a 
incubator set at 37°C.  
 
Palmitate and BSA  
 Palmitate (Sigma) was dissolved in DMSO to achieve a concentration of 
0.4M and this solution was dissolved at 56°C in RPMI 1640 media containing 5% 
fatty acid-free BSA (Calbiochem) to make a 10x stock. RPMI 1640 media 
containing 5% BSA and 1% DMSO was used as a control. On the day of the 
experiment, the both stocks were added to a variation of the aforemention INS1 
media containing only 1% FBS. In addition, 1M glucose was added to the 
palmitate containing media in a 1:100 ratio. These solutions were filtered and 
then added to their respective quadrant dish and remained there for 
approximately 18 hours before imaging. 
 
TMRE   
 Tetramethylrhodamine, ethyl ester perchlorate (TMRE) is a cell permeant, 
cationic, red-orange dye that is taken up by active mitochondria in a membrane 
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dependent manner. A higher amount of TMRE present in mitochondria equates 
to a higher membrane potential. 1uL of the TMRE was added to 1000uL of 
DMSO and 10uL of the resulting solution was dissolved in 10mL of INS1 media, 
which was added to the cells 30 minutes prior to imaging. Since the TMRE is 
light sensitive, it was wrapped in aluminum foil during the preparation of the 
TMRE containing media.  
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Figure 3: Sequence of steps in the present experiment.  
 
 
Imaging and Data Analysis 
The samples housed in quadrant dishes were imaged using a confocal 
microscope at a 40x magnification. Images were analyzed using Image J 
software (National Institutes of Health). An unpaired t test was used to validate 
statistical differences. P = 0.05 was the cut off point for statistical significance.  
 
Making Agar Plates  
6.4 grams of agar and 200ml of DH20 were autoclaved in an aluminum foil 
covered 200ml Erlenmeyer flask at cycle setting of Gravity 30 for sixty seven 
minutes. Following cooling of the mixture, 200µl of ampicillin was added and the 
subsequent mixture was poured into approximately twenty petri dishes. 
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RESULTS 
Representative Images  
The data collection method for these experiments was dependent on the 
imaging of cells at multiple wavelengths of color or florescence intensity. Thus, 
when the laser of the confocal microscope was activated, the mitochondria 
chosen for imaging were those that appeared yellow. A cell with yellow 
mitochondria showed that both the DNA bound to GFP had been transfected and 
that the TMRE dye had accumulated in the mitochondrial population. By 
analyzing these images in either the green, red, or merged form, we were able to 
discern the following data   (Figure 4).  
 A (BSA Control DNA)   GFP              TMRE                      Merged  
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B (BSA DJ-1 WT)             GFP  TMRE                   Merged 
   
 
 
C (GLT Control DNA)     GFP     TMRE                        Merged                          
   
D (GLT DJ-1WT)      GFP              TMRE                          Merged        
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Figure 4: Representative images of 4 INS1 treatment groups. Only experimental 
treatment groups from successful GLT treatment experiment are included.  
 
Mean Membrane Potential and Heterogeneity Results 
Measurements of ∆ᴪm were found by analyzing the ratio of TMRE to 
mitochondrial GFP. For the control DNA group, the GLT treatment yielded a ∆ᴪm 
that was 192.87% of the BSA control (P = 0.0156). In addition, for DJ-1 WT 
group of cells, the GLT treatment yielded a ∆ᴪm that was 98.57% of that of the 
BSA control while the BSA treatment for the DJ-1 WT group only showed 63.42% 
(P = 0.0215)(Figure 5A, n = 5-8).  
In a repetition of the experiment, an inefficient GLT treatment yielded a 
non-significant increase in ∆ᴪm that was only 104.99% of the BSA control. Due to 
this inefficiency, the values for other variables tested in this experiment such as 
heterogeneity and morphology did not merit reporting in this document. The 
values for ∆ᴪm though, shed light on the fact that the GLT treated DJ-1 WT and 
the DJ-1 C106A expressing groups both showed a significant decrease in ∆ᴪm 
and were 65.08% and 66.13% of the level of the BSA control respectively (P = 
0.0009, P = 0.0196). In addition, these two measurements were not significantly 
different from each other (P = 0.1051) (Figure 5B, n = 4-6).  
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Figure 5: Assessment of ∆ᴪm using TMRE. (A) Highly efficient GLT treatment. 
(B) Inefficient GLT treatment. Error bars represent standard deviations and all 
values are expressed as a percentage of the control BSA experimental group. 
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Heterogeneity of the ∆ᴪm was found by analyzing the raw standard 
deviations of the TMRE reading for ∆ᴪm. In addition, the GLT treatment resulted 
in a level of heterogeneity 192.86% as great as that of the BSA control, but this 
was not significant due to the large standard deviation between the two. It is 
noteworthy to state that there was nearly a significant difference between the 
BSA and GLT treated cells expressing DJ-1 (P = 0.0649)(Figure 6A, n=5-8).  
In a repetition of the experiment, an inefficient GLT treatment yielded a 
non-significant decrease in content heterogeneity that was merely 92.54% of the 
BSA control. The GLT treated DJ-1 WT expressing group showed an increase in 
content heterogeneity and was 101.49% as great as the BSA control value. 
(Figure 6B, n = 4-6).   
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Figure 6: Assessment of mitochondrial content heterogeneity. This was 
measured by using the standard deviation of ∆ᴪm in B-cells. (A) Highly efficient 
GLT treatment. (B) Inefficient GLT treatment. Error bars represent standard 
deviations and all values are expressed as a percentage of the control BSA 
experimental group.  
 
Morphology Results 
Feret’s diameter was one tool we used to measure mitochondrial 
morphology. The GLT treatment caused a Feret’s diameter measurement of 
79.58% of the control BSA group (P = 0.0331). For cells expressing DJ-1,there 
was no significant difference between the Feret’s diameter of the cells treated 
with BSA compared to GLT. The fact that there is no significant change between 
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the two DJ-1 groups while there is a significant change with the two control 
groups says that DJ-1 prevents this significant change. (Figure 7A, n = 4-6). 
In a repetition of the experiment, an inefficient GLT treatment yielded a 
non-significant increase in ferret’s diameter that was 114.89% of that of the BSA 
control. The DJ-1 WT expressing cells showed a significant increase in Feret’s 
diameter, measuring 165.65% of that of the BSA control (P = 0.0414). The DJ-1 
C106A expressing group showed a slight decrease in Feret’s diameter, 
measuring 101.53% of that of the BSA control (Figure 7B, n = 4-6). 
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Figure 7: Assessment of DJ-1’s potential in altering mitochondrial morphology in 
pancreatic B-cells by measuring Feret’s diameter. (A) Highly efficient GLT 
treatment. (B) Inefficient GLT treatment. Error bars represent standard deviations 
and all values are expressed as a percentage of the control BSA experimental 
group. 
 
Another way we measured mitochondrial morphology was by assessing 
aspect ratio. The GLT treatment yielded cells with an aspect ratio 81.68% as 
great as that of the control BSA group (P = 0.0188). The GLT treated cells 
expressing DJ-1 WT did not show a significant reversal of the previous effect, 
only showing an aspect ratio measurement of 89.60% of the control BSA group’s 
measurement (Figure 8A, n = 5-8).  
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In a repetition of the experiment, an inefficient GLT treatment yielded a 
non-significant decrease in aspect ratio that was 94.21% of that of the BSA 
control. In addition, the DJ-1 WT expressing cells also showed a decrease in 
aspect ratio, measuring 93.16% of the control BSA group. (Figure 8B, n = 4-6). 
 
 
 
27 
 
Figure 8: Assessment of DJ-1 potential in altering mitochondrial morphology in 
pancreatic B-cells by measuring aspect ratio. Error bars represent standard 
deviations and all values are expressed as a percentage of the control BSA 
experimental group.  
 
Form factor was another tool we used to measure mitochondrial 
morphology. The GLT treatment showed cells with a form factor 79.75% as great 
as the form factor of the control BSA group. This was a significant decrease in 
form factor (P = 0.0346). In addition, for the cells expressing DJ-1, there was not 
a significant difference between the BSA and GLT treated groups (P =  0.5484) 
(Figure 9A, n = 5-8).  
In a repetition of the experiment, an inefficient GLT treatment yielded a 
non-significant decrease in form factor measuring 90.17% of that of the control 
BSA group. In addition, the DJ-1 WT expressing cells showed an increase in 
form factor measuring 105.78% of that of the control BSA group (Figure 9B, n = 
4-6). 
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Figure 9: Quantification of DJ-1 potential in altering mitochondrial morphology in 
pancreatic B-cells by measuring form factor. Error bars represent standard 
deviations and all values are expressed as a percentage of the control BSA 
experimental group.  
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BSA DJ-1 Merged 
 
Figure 10: Representative images of the merged BSA Con and DJ-1 Con.  
  
For the cells expressing DJ-1 WT, DJ-1 was able to significantly 
decreased the average number of APs from 84.38% of the BSA control to 
62.87% (P = 0.014)(Figure 11).   
  
31 
 
 
Figure 11: Assessment of average number of autophagosomes. 
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DISCUSSION 
 
This study deals with the potential of the gene DJ-1 to act as a sensor for 
oxidative stress in order to enhance mitochondrial quality control. A mitochondrial 
model for glucolipotocity in INS1 cells was used to study type 2 diabetes.   
The Image J software supplied a means to assess mitochondrial 
morphology in terms of three variables: Feret’s diameter, aspect ratio, and form 
factor. All three of these morphology measurements showed the same effect. 
The GLT treatment was able to significantly increase all three measurements in 
cells that were not expressing DJ-1. The absence of a significant decrease in 
these three measurements for the GLT treated DJ-1 expressing group showed 
that DJ-1 significantly reverses morphology changes due to glucolipotoxicity. The 
finding for Feret’s diameter, the measurement of the largest line through the 
mitochondria, agrees with previous studies that say that healthy mitochondria are 
more likely to be elongated in shape and form networks with other mitochondria.  
This significant effect fits well with our understanding of aspect ratio as 
well. Since aspect ratio is the measurement of the major axis divided by the 
minor axis, the lowest value is 1, a perfect circle. Thus, a low value  is a good 
indicator for a fragmented mitochondria. Since during the GLT treatment, the cell 
is more likely to produce more isolated mitochondria that have accrued oxidative 
damage, these cells are more likely to be fragmented in shape and so a lower 
aspect ratio is understandable. Since there was not such a comparative change 
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in morphology in the DJ-1 expressing cells treated with BSA or GLT, the effect 
shown through aspect ratio is very informative.   
Form factor, the measurement of theoretical area by actual area is an 
indicator of the level of branching found in a mitochondria such that a perfect 
circle scores the lowest value, 1. Since there was no significant decrease in form 
factor in the DJ-1 expressing cells while there was there was in the control GLT 
treatment, DJ-1 significantly shows a reverse in the morphology change. 
Together, Feret’s diameter, aspect ratio, and form factor make a convincing case 
for DJ-1’s ability to enhance quality control by reversing changes in morphology.  
After many failed attempts and continued optimization of the experiment, a 
significant increase in mitochondrial membrane potential was found in GLT 
treated cells expressing control DNA. This relationship served to distinguish 
trustworthy results from nebulous findings in relation to the GLT treatment. While 
DJ-1 successfully reversed changes in morphology, it was not able to 
significantly reverse changes in mean membrane potential caused by GLT 
treatment.  
 Despite the aforementioned test for validity, data from an inefficient GLT 
treatment yielded interesting result in the realm of mean membrane potential 
measurements. Together, both experiments showed that DJ-1 does limit the 
maximal mean membrane potential reached under the GLT treatment. In 
addition, this partially GLT treated experiment supports the claim that DJ-1 
mediates a decrease in mean membrane potential that does not stem from the 
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function of the C106A region. This observation shows that there could be a 
multitude of different active sites on the protein for possible interaction. The 
mapping of such alternative sites of activity would open up new avenues for 
modulation of DJ-1 activity and thus hold great potential for eventual clinical use.  
Our data for heterogeneity of the mitochondrial population did not yield 
any significant results. Still though, the increase found in the GLT group 
compared to the BSA group for the cells expressing DJ-1just barely missed being 
a significant change (P = 0.0649). This trend could easily translate to a significant 
effect in heterogeneity if the sample size was increased. An increase in 
heterogeneity would fit in well with our understanding of DJ-1 function. Such an 
increase would mean that mitochondria which consolidate damaged materials 
are cleared slower, and so the membrane potential in the mitochondrial 
population shows more heterogeneity. The GLT treatment has been shown to 
promote complementation between the glucose and palmitate, yielding a 
significant decrease in autophagic flux (Las et al 2011). This was originally found 
through the connection between glucolipotoxicity induced cell death and buildup 
of APs (Las et al 2011). Thus future studies should quantify GLT induced cell.  
We performed the same GLT based DJ-1 experiment using INS1 cells 
expressing GFP-LC3. The addition of the GLT treatment to cells expressing DJ-1 
showed a significant decrease in the average number of autophagosomes 
present in the cells. This can either be due to increased clearance through 
autophagy or a decreased production of autophagosome.  
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Future studies involving DJ-1’s potential in enhancing quality control would 
incorporate cell viability measurement and oxygen consumption in order to better 
understand DJ-1‘s ultimate effects on pancreatic B-cells.  
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